iFood has announced an impressive 80% growth in its pharmaceutical product sales by the end of 2025, marking a significant expansion in its operations. The company's customer base has also grown by 43%, with around 20,000 stores involved in the service across nearly 900 cities in Brazil. This represents a 30% increase compared to the end of 2024, showcasing iFood's strategic improvements in their service delivery.

The growth is attributed to the implementation of a rapid delivery model, allowing customers to receive their orders in as little as ten minutes, tailored specifically for urgent requests in the pharmaceutical sector. This model aligns well with the evolving needs of consumers, particularly as they seek faster access to healthcare products. Since its diversification into pharmacy products began in 2019, iFood has redefined its market outreach beyond traditional food delivery services.

Looking ahead, iFood has set ambitious goals for 2026, aiming to expand its partnerships in health, beauty, and wellness sectors, ultimately broadening its portfolio of brands and services. While the company has not disclosed specific projections for the upcoming year, its past performance suggests a strong potential for continued growth and innovation in the delivery sector, particularly in pharmaceuticals.